Endoscopy 2020; 52(S 01): S162
DOI: 10.1055/s-0040-1704500
ESGE Days 2020 ePoster Podium presentations
Friday, April 24, 2020 09:30 – 10:00 Neuroendocrine tumors ePoster Podium 3
© Georg Thieme Verlag KG Stuttgart · New York

EUS-GUIDED RADIOFREQUENCY ABLATION OF RECURRENT PANCREATIC NON-FUNCTIONAL NEUROENDOCRINE TUMORS AFTER DISTAL PANCREATECTOMY IN A PATIENT WITH MEN1

T Greener
1   Hebrew University, Digestive Diseases Institute, Jerusalem, Israel
,
A Dancour
1   Hebrew University, Digestive Diseases Institute, Jerusalem, Israel
› Author Affiliations
Further Information

Publication History

Publication Date:
23 April 2020 (online)

Also available at
 

A 48-year-old man with a history of MEN1 syndrome that underwent distal pancreatectomy for multiple pancreatic non-functional neuroendocrine tumors, was referred for EUS after a new lesion in segment 3 of the liver was detected on a 68-Ga-DOTATOC PET/CT scan, 18 months after surgery, while receiving Lanreotide. On EUS another 5 mm lesion was detected in head of pancreas.

Both lesions were successfully treated with EUS-guided radiofrequency ablation (RFA). At one-year following ablation treatment, both Ga-DOTATOC PET/CT scan and standard EUS including contrast-enhanced EUS were negative for any recurrent lesions.